Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M4XH
|
||||
Former ID |
DNC013726
|
||||
Drug Name |
1-Ethylidenethiosemicarbazide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C3H7N3S
|
||||
Canonical SMILES |
CC=NNC(=S)N
|
||||
InChI |
1S/C3H7N3S/c1-2-5-6-3(4)7/h2H,1H3,(H3,4,6,7)/b5-2-
|
||||
InChIKey |
OOPAKHKIEGNKDU-DJWKRKHSSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tyrosine oxidase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | (S)-reticuline biosynthesis | ||||
Eumelanin biosynthesis | |||||
L-dopachrome biosynthesis | |||||
KEGG Pathway | Tyrosine metabolism | ||||
Riboflavin metabolism | |||||
Metabolic pathways | |||||
Melanogenesis | |||||
PathWhiz Pathway | Riboflavin Metabolism | ||||
Tyrosine Metabolism | |||||
WikiPathways | Dopamine metabolism | ||||
References | |||||
REF 1 | Eur J Med Chem. 2009 Apr;44(4):1773-8. Epub 2008 Apr 27.A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.